1. Cacace, R, Sleegers, K, Van Broeckhoven, C. Molecular genetics of early‐onset alzheimer’s disease revisited. Alzheimers Dement 2016; 12(6): 733–748.
Google Scholar | Crossref | Medline2. Hashemiaghdam, A, Mroczek, M. Microglia heterogeneity and neurodegeneration: the emerging paradigm of the role of immunity in Alzheimer’s disease. J Neuroimmunol 2020; 341: 577185.
Google Scholar | Crossref | Medline3. Jimenez, S, Baglietto-Vargas, D, Caballero, C, et al. Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer’s disease: age-dependent switch in the microglial phenotype from alternative to classic. J Neurosci 2008; 28(45): 11650–11661.
Google Scholar | Crossref | Medline | ISI4. Tang, Y, Le, W. Differential Roles of M1 and M2 Microglia in neurodegenerative diseases. Mol Neurobiol 2016; 53(2): 1181–1194.
Google Scholar | Crossref | Medline5. Kelley, N, Jeltema, D, Duan, Y, et al. The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. Int J Mol Sci 2019; 20(13).
Google Scholar | Crossref | Medline6. Song, N, Li, T. Regulation of NLRP3 Inflammasome by Phosphorylation. Front Immunol 2018; 9: 2305.
Google Scholar | Crossref | Medline7. Yang, Y, Wang, H, Kouadir, M, et al. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis 2019; 10(2): 128.
Google Scholar | Crossref | Medline8. Mangan, MSJ, Olhava, EJ, Roush, WR, et al. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov 2018; 17(8): 588–606.
Google Scholar | Crossref | Medline9. Kuwar, R, Rolfe, A, Di, L, et al. A novel inhibitor targeting NLRP3 inflammasome reduces neuropathology and improves cognitive function in Alzheimer’s disease transgenic mice. J Alzheimers Dis 2021; 82(4): 1769–1783.
Google Scholar | Crossref | Medline10. Dempsey, C, Rubio Araiz, A, Bryson, KJ, et al. Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice. Brain Behav Immun 2017; 61: 306–316.
Google Scholar | Crossref | Medline11. Heneka, MT, Kummer, MP, Stutz, A, et al. NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature 2013; 493(7434): 674–678.
Google Scholar | Crossref | Medline | ISI12. Yin, J., Zhao, F., Chojnacki, J. E., et al. NLRP3 Inflammasome Inhibitor Ameliorates Amyloid Pathology in a Mouse Model of Alzheimer’s Disease. Mol Neurobiol 2018; 55(3): 1977–1987.
Google Scholar | Crossref | Medline13. Fu, Q, Wu, J, Zhou, X-Y, et al. NLRP3/Caspase-1 pathway-induced pyroptosis mediated cognitive deficits in a mouse model of sepsis-associated encephalopathy. Inflammation 2019; 42(1): 306–318.
Google Scholar | Crossref | Medline14. Fan, Y, Du, L, Fu, Q, et al. Inhibiting the NLRP3 inflammasome with MCC950 Ameliorates Isoflurane-Induced Pyroptosis and cognitive impairment in aged mice. Front Cell Neurosci 2018; 12: 426.
Google Scholar | Crossref | Medline15. Ising, C, Venegas, C, Zhang, S, et al. NLRP3 inflammasome activation drives tau pathology. Nature 2019; 575(7784): 669–673.
Google Scholar | Crossref | Medline16. Kunnumakkara, AB, Bordoloi, D, Padmavathi, G, et al. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol 2017; 174(11): 1325–1348.
Google Scholar | Crossref | Medline17. Zhang, J, Zheng, Y, Luo, Y, et al. Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2/TLR4/NF-κB pathways in BV2 cells. Mol Immunol 2019; 116: 29–37.
Google Scholar | Crossref | Medline18. Mei, X, Zhu, L, Zhou, Q, et al. Interplay of curcumin and its liver metabolism on the level of Aβ in the brain of APPswe/PS1dE9 mice before AD onset. Pharmacol Rep 2020; 72(6): 1604–1613.
Google Scholar | Crossref | Medline19. Xu, P, Li, Z, Wang, H, et al. Triptolide inhibited Cytotoxicity of differentiated PC12 cells induced by Amyloid-Beta25-35 via the autophagy pathway. PLoS One 2015; 10(11): e0142719.
Google Scholar | Crossref | Medline20. Wang, S, Xia, B, Qiao, Z, et al. Tetramethylpyrazine attenuated bupivacaine-induced neurotoxicity in SH-SY5Y cells through regulating apoptosis, autophagy and oxidative damage. Drug Des Devel Ther 2019; 13: 1187–1196.
Google Scholar | Crossref | Medline21. Fu, W, Vukojevic, V, Patel, A, et al. Role of microglial amylin receptors in mediating beta amyloid (Aβ)-induced inflammation. J Neuroinflammation 2017; 14(1): 199.
Google Scholar | Crossref | Medline22. Hong, Y, Liu, Y, Yu, D, et al. The neuroprotection of progesterone against Aβ-induced NLRP3-Caspase-1 inflammasome activation via enhancing autophagy in astrocytes. Int Immunopharmacol 2019; 74: 105669.
Google Scholar | Crossref | Medline23. Newcombe, EA, Camats-Perna, J, Silva, ML, et al. Inflammation: the link between comorbidities, genetics, and Alzheimer’s disease. J Neuroinflammation 2018; 15(1): 276.
Google Scholar | Crossref | Medline24. Mendiola, AS, Cardona, AE. The IL-1β phenomena in neuroinflammatory diseases. J Neural Transm (Vienna) 2018; 125(5): 781–795.
Google Scholar | Crossref | Medline25. Das, A, Chai, JC, Kim, SH, et al. Dual RNA sequencing reveals the expression of unique transcriptomic signatures in lipopolysaccharide-induced BV-2 microglial cells. PLoS One 2015; 10(3): e0121117.
Google Scholar | Crossref | Medline | ISI26. de Medeiros, LM, De Bastiani, MA, Rico, EP, et al. Cholinergic differentiation of human neuroblastoma SH-SY5Y cell line and its potential use as an in vitro model for Alzheimer’s disease studies. Mol Neurobiol 2019; 56(11): 7355–7367.
Google Scholar | Crossref | Medline27. Jin, X, Liu, MY, Zhang, DF, et al. Baicalin mitigates cognitive impairment and protects neurons from microglia‐mediated neuroinflammation via suppressing NLRP 3 inflammasomes and TLR 4/NF ‐κB signaling pathway. CNS Neurosci Ther 2019; 25(5): 575–590.
Google Scholar | Crossref | Medline28. He, W, Yuan, K, Ji, B, et al. Protective effects of curcumin against neuroinflammation induced by Aβ25-35 in primary rat microglia: modulation of high-mobility group box 1, toll-like receptor 4 and receptor for advanced glycation end products expression. Ann Transl Med 2020; 8(4): 88.
Google Scholar | Crossref | Medline